186 related articles for article (PubMed ID: 16520012)
1. Ionization, lipophilicity and solubility properties of repaglinide.
Mandić Z; Gabelica V
J Pharm Biomed Anal; 2006 Jun; 41(3):866-71. PubMed ID: 16520012
[TBL] [Abstract][Full Text] [Related]
2. Determination of protonation macro- and microconstants and octanol/water partition coefficient of the antiinflammatory drug niflumic acid.
Takács-Novák K; Avdeef A; Box KJ; Podányi B; Szász G
J Pharm Biomed Anal; 1994 Nov; 12(11):1369-77. PubMed ID: 7849133
[TBL] [Abstract][Full Text] [Related]
3. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M
Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
[TBL] [Abstract][Full Text] [Related]
4. Rapidly dissolving repaglinide powders produced by the ultra-rapid freezing process.
Purvis T; Mattucci ME; Crisp MT; Johnston KP; Williams RO
AAPS PharmSciTech; 2007 Jul; 8(3):E58. PubMed ID: 17915808
[TBL] [Abstract][Full Text] [Related]
5. Modeling solubility, acid-base properties and activity coefficients of amoxicillin, ampicillin and (+)6-aminopenicillanic acid, in NaCl(aq) at different ionic strengths and temperatures.
Crea F; Cucinotta D; De Stefano C; Milea D; Sammartano S; Vianelli G
Eur J Pharm Sci; 2012 Nov; 47(4):661-77. PubMed ID: 22903046
[TBL] [Abstract][Full Text] [Related]
6. Protonation equilibrium and lipophilicity of moxifloxacin.
Langlois MH; Montagut M; Dubost JP; Grellet J; Saux MC
J Pharm Biomed Anal; 2005 Feb; 37(2):389-93. PubMed ID: 15708683
[TBL] [Abstract][Full Text] [Related]
7. [Physico-chemical profiling of centrally acting molecules for prediction of pharmacokinetic properties].
Deák K
Acta Pharm Hung; 2008; 78(3):110-20. PubMed ID: 18986088
[TBL] [Abstract][Full Text] [Related]
8. Fundamental properties of local anesthetics. I. The dependence of lidocaine's ionization and octanol:buffer partitioning on solvent and temperature.
Sanchez V; Arthur GR; Strichartz GR
Anesth Analg; 1987 Feb; 66(2):159-65. PubMed ID: 3813059
[TBL] [Abstract][Full Text] [Related]
9. Lipophilicity of zwitterions and related species: a new insight.
Mazák K; Kökösi J; Noszál B
Eur J Pharm Sci; 2011 Sep; 44(1-2):68-73. PubMed ID: 21726635
[TBL] [Abstract][Full Text] [Related]
10. Coamorphous repaglinide-saccharin with enhanced dissolution.
Gao Y; Liao J; Qi X; Zhang J
Int J Pharm; 2013 Jun; 450(1-2):290-5. PubMed ID: 23612357
[TBL] [Abstract][Full Text] [Related]
11. Co-solvent solubilization of some poorly-soluble antidiabetic drugs.
Seedher N; Kanojia M
Pharm Dev Technol; 2009; 14(2):185-92. PubMed ID: 19519190
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between the structures and physicochemical properties of chemotherapeutic fluoroquinolone agents].
Szász G; Takácsné NK; Budváriné BZ; Hermecz I; Józan M; Lóre A; Noszál B
Acta Pharm Hung; 1993 May; 63(3):105-14. PubMed ID: 8362651
[TBL] [Abstract][Full Text] [Related]
13. Theoretical study of gas-phase acidity, pKa, lipophilicity, and solubility of some biologically active sulfonamides.
Remko M; von der Lieth CW
Bioorg Med Chem; 2004 Oct; 12(20):5395-403. PubMed ID: 15388166
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis and investigation of protonation properties and lipophilicity of some new quinazolone-3-carboxylic acid derivatives].
Almási J; Kökösi J; Takácsné NK; Vámos J; Noszál B
Acta Pharm Hung; 1999 Sep; 69(4):193-201. PubMed ID: 10544519
[TBL] [Abstract][Full Text] [Related]
15. Insights into structure-activity relationships from lipophilicity profiles of pyridin-2(1H)-one analogs of the cardiotonic agent milrinone.
de Candia M; Fossa P; Cellamare S; Mosti L; Carotti A; Altomare C
Eur J Pharm Sci; 2005 Sep; 26(1):78-86. PubMed ID: 15955679
[TBL] [Abstract][Full Text] [Related]
16. The physicochemical properties and the in vivo AChE inhibition of two potential anti-Alzheimer agents, bis(12)-hupyridone and bis(7)-tacrine.
Yu H; Li WM; Kan KK; Ho JM; Carlier PR; Pang YP; Gu ZM; Zhong Z; Chan K; Wang YT; Han YF
J Pharm Biomed Anal; 2008 Jan; 46(1):75-81. PubMed ID: 17931815
[TBL] [Abstract][Full Text] [Related]
17. The difference between partitioning and distribution from a thermodynamic point of view: NSAIDs as an example.
Perlovich GL; Kurkov SV; Bauer-Brandl A
Eur J Pharm Sci; 2006 Feb; 27(2-3):150-7. PubMed ID: 16253486
[TBL] [Abstract][Full Text] [Related]
18. Theoretical study of structure, pKa, lipophilicity, solubility, absorption, and polar surface area of some centrally acting antihypertensives.
Remko M; Swart M; Bickelhaupt FM
Bioorg Med Chem; 2006 Mar; 14(6):1715-28. PubMed ID: 16263295
[TBL] [Abstract][Full Text] [Related]
19. Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies.
Ruzilawati AB; Wahab MS; Imran A; Ismail Z; Gan SH
J Pharm Biomed Anal; 2007 Apr; 43(5):1831-5. PubMed ID: 17240100
[TBL] [Abstract][Full Text] [Related]
20. [Practical aspects of partition measurements according to GLP rules].
Takácsné Novák K
Acta Pharm Hung; 1997 Sep; 67(5):179-91. PubMed ID: 9432865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
